The Hsp90 molecular chaperone and its Cdc37 co-chaperone help stabilize and activate over half of the human kinome. However, neither the mechanism by which these chaperones assist their client kinases nor why some kinases are addicted to Hsp90 while closely related family members are independent is known. Missing has been any structural understanding of these interactions, with no full-length structures of human Hsp90, Cdc37 or either of these proteins with a kinase. Here we report a 3.9Å cryoEM structure of the Hsp90:Cdc37:Cdk4 kinase complex. Cdk4 is in a novel conformation, with its two lobes completely separated. Cdc37 mimics part of the kinase Nlobe, stabilizing an open kinase conformation by wedging itself between the two lobes. Finally, Hsp90 clamps around the unfolded kinase β5 strand and interacts with exposed N-and C-lobe interfaces, protecting the kinase in a trapped unfolded state. Based on this novel structure and extensive previous data, we propose unifying conceptual and mechanistic models of chaperonekinase interactions.
Main TextThe human kinome is responsible for regulating about a third of all proteins through phosphorylation(1). Proper regulation of this process is important, as misregulated kinase activity can lead to cell death and disease(2). To achieve fine regulation, kinase activity can be sensitively modulated by multiple allosteric inputs. Thus, kinase domains are organized so that dispersed small structural changes caused by binding of regulatory domains/proteins or phosphorylation, can significantly alter kinase activity. Examples of such regulator interactions abound, via SH2/SH3 domains for Src family kinases, dimerization for EGFR or Raf family kinases, and cyclin regulation for Cdks being well characterized examples(3).
Author Manuscript Author ManuscriptAuthor Manuscript
Author ManuscriptBeyond these specific regulators, the Hsp90 molecular chaperone, a member of the general cellular protein folding machinery, also plays a fundamental role in the regulation of many kinases(4). While usually chaperones facilitate the early steps of protein folding, Hsp90 also functions late in the folding process to help both fold and activate a set of protein "clients" (~10% of the proteome)(5). Notably ~60% of the human kinome interacts with Hsp90 with the assistance of its kinase specific cochaperone Cdc37(6). Pharmocologic inhibition of Hsp90 leads to rapid ubiquitinylation and degradation of client kinases. As many Hsp90/ Cdc37-dependent kinases are key oncoproteins, (vSrc, bRafV600E, Her2, etc.) several Hsp90 inhibitors are undergoing clinical trials as cancer therapeutics(7).Hsp90 is a well conserved, but highly dynamic molecular machine. Each monomer within the Hsp90 dimer has three structural domains: a C-terminal domain (CTD) responsible for dimerization; a middle domain (MD) implicated in client binding; and the N-terminal domain (NTD) that binds ATP. Without bound nucleotide, Hsp90 mostly populates a variety of "open" states, whereas nucleotide binding promotes formation of...